Invokana Diabetes Drug Adds Risk of Amputation Warning
Diabetes Drug Invokana Linked to Heightened Risk of Amputation. The diabetes drug canagliflozin, which is sold under several brand names, including Invokana, Invokamet, and Invokamet XR is now sold with the FDA’s most serious form of warning label, the Black Box Warning. The decision to require the drug’s manufacturers, such as … [Read more...] about Invokana Diabetes Drug Adds Risk of Amputation Warning
Diabetes Drug, Actos, and the Risks of Bladder Cancer and Other Serious Side Effects
Diabetes Drug Risk Of Cancer And Other Side Effects. The U.S. Food and Drug Administration (FDA) approved Actos, which is manufactured by Takeda Chemical Industries, on July 15, 1999. Actos includes the active ingredient pioglitazone hydrochloride and is used for treatment of Type 2 and Type 1 diabetes; Type 1 diabetes mellitus; … [Read more...] about Diabetes Drug, Actos, and the Risks of Bladder Cancer and Other Serious Side Effects
Actos Heart Attack Lawsuit | Actos Lawsuits
Actos Heart Attack Injury Lawsuits. If you or someone you love have used the diabetes drug Actos, and suffered an Actos heart attack, this popular type 2 diabetes drug could be to blame. Recent research has linked Actos and other type 2 diabetes drugs known as thiazolidinediones with the side effects of heart attacks, strokes and … [Read more...] about Actos Heart Attack Lawsuit | Actos Lawsuits
Controversial Diabetes Drug Actos Still on the Market
Though research has shown an association between the type 2 diabetes drug Actos and serious side effects including bladder cancer, heart failure, liver failure, and bone fractures, the Food and Drug Administration (FDA) has stopped short of recalling Actos. Actos (pioglitazone) has been pulled from the market in Germany, France, … [Read more...] about Controversial Diabetes Drug Actos Still on the Market
Lawsuit Charges Drugmaker Hushed Actos Cancer Reports
Civil Suits Against The Makers of Actos. A whistleblower lawsuit against the makers of the diabetes drug Actos could make it easier for consumers harmed by the medication to seek relief in civil suits against the manufacturer. Lawsuit claims drugmaker Takeda failed to disclose cancer and heart failure related to usage of Actos … [Read more...] about Lawsuit Charges Drugmaker Hushed Actos Cancer Reports
Lawsuit Alleges Invokana Caused Stroke
a lawsuit alleging its diabetes drug Invokana caused a stroke The Risky Effect of Invokana Diabetes Drug. Johnson & Johnson, and its subsidiary, Janssen Pharmaceuticals, face a lawsuit alleging its diabetes drug Invokana caused a stroke. The suit was filed in New Jersey on behalf of a plaintiff who began taking the drug in … [Read more...] about Lawsuit Alleges Invokana Caused Stroke
Nevada Jury Hears Actos Case
A lawsuit alleging that Takeda's Type 2 diabetes drug Actos caused bladder cancer has gone to trial in Las Vegas, Nevada. Judge Jerry Wiese is presiding over the case in the Supreme Court of the State of Nevada. The suit was filed on behalf of two Actos users who were diagnosed with bladder cancer, allegedly due to use of the drug. … [Read more...] about Nevada Jury Hears Actos Case
FDA Warns about Bone Fracture Risks with Invokana
The Food and Drug Administration (FDA) has updated the warning label of the type 2 diabetes drug canagliflozin (Invokana, Invokamet) to warn about the increased risk of bone fractures and reduced bone mineral density for those taking canagliflozin. This warning comes soon after an FDA warning in May in which the agency said … [Read more...] about FDA Warns about Bone Fracture Risks with Invokana
FDA Issues Another Warning for Type 2 Diabetes Drug
Late last month, the U.S. Food and Drug Administration (FDA) warned that diabetes medications such as sitagliptin, saxagliptin, linagliptin and alogliptin could lead to “severe and disabling” joint pain. The agency said in a safety announcement that this risk would be added to the labels of all medicined in the dipeptidyl peptidase-4 … [Read more...] about FDA Issues Another Warning for Type 2 Diabetes Drug
FDA Warns of Diabetes Drugs that Can Cause Disabling Joint Pain
On Friday, the Food and Drug Administration (FDA) warned diabetes patients that an entire class of diabetes drugs can cause severe and disabling joint pain. The drugs include Januvia (sitagliptin), Onglyza (saxagliptin), Tradjenta (linagliptin) and Nesina (alogliptin). They are all in the same class and work by making more insulin … [Read more...] about FDA Warns of Diabetes Drugs that Can Cause Disabling Joint Pain
AstraZeneca Diabetes Drug Onglyza May be Associated with Increased Rate of Death
Onglyza Rate Of Death. After a preliminary review of data, the Food and Drug Administration (FDA) reports that AstraZeneca's diabetes drug Onglyza (saxagliptin) may be associated with an increased rate of death. The FDA's report was posted on the agency's website on Friday, a few days ahead of an April 14 FDA advisory panel … [Read more...] about AstraZeneca Diabetes Drug Onglyza May be Associated with Increased Rate of Death
FDA Says Diabetes Drug Onglyza May be Linked to Higher Death Rate
After conducting a preliminary review of data, the U.S. Food and Drug Administration (FDA) has issued a report indicating that AstraZeneca’s diabetes drug Onglyza may be linked with an increased rate of death. According to Reuters, an FDA advisory panel will meet on April 14 to discuss he risks of Onglyza and another similar … [Read more...] about FDA Says Diabetes Drug Onglyza May be Linked to Higher Death Rate
FDA identifies stumbling blocks for new diabetes drug
Rash of Diabetes Drug Side Effects. The Food and Drug Administration issued a statement this week indicating that a clinical trial of a new type 2 diabetes drug has suffered some setbacks as there have been a rash of dangerous side effects reported among its participants. According to a Reuters report, the FDA published a report … [Read more...] about FDA identifies stumbling blocks for new diabetes drug
Kentucky Man’s Death Blamed on Actos
Bladder Cancer Blamed to Diabetes Drug Actos. The death of a Kentucky man due to bladder cancer is being blamed on the type 2 diabetes drug Actos in a federal lawsuit recently filed on behalf of his estate. The Plaintiff-Decedent is being represented by the national law firm of Parker Waichman LLP and the lawsuit has … [Read more...] about Kentucky Man’s Death Blamed on Actos
Avandia Bisphosphonate Weaknesses Problems
Avandia, Bisphosphonate Problems. Recent safety issues involving the diabetes drug Avandia and a class of bone drugs called bisphosphonates have some questioning the way drugs are approved for sale in the US. According to a recent New York Times’ news analysis, problems that have cropped up with Avandia, bisphosphonates and other … [Read more...] about Avandia Bisphosphonate Weaknesses Problems
Avandia Disclosures Prompt FDA Probe
Data On Avandia Heart Risks. Avandia may be about to cause more trouble for GlaxoSmithKline. According to a report in TIME Magazine, the US Food & Drug Administration (FDA) is trying to determine if Glaxo broke the law when it didn’t disclose data on the controversial diabetes drug’s heart risks. Since November 2007, Avandia’s … [Read more...] about Avandia Disclosures Prompt FDA Probe
Avandia Decision Looms for FDA
FDA Will Discuss The Safety Of Avandia. In two weeks, a U.S. Food & Drug Administration (FDA)Â advisory panel will meet to discuss the safety of the controversial diabetes drug, Avandia. In the past, the Avandia issue has sharply divided the agency. However, over the past several years, concerns about Avandia side effects have … [Read more...] about Avandia Decision Looms for FDA
Glaxo Settled 700 Avandia Lawsuits
Glaxo Settled Avandia Lawsuits. GlaxoSmithKline has reportedly settled around 700 Avandia lawsuits. According to a Bloomberg report, the drug maker has agreed to pay out $60 million to people who claimed the controversial diabetes drug caused them to suffer a heart attack or stroke. While more than 4,000 Avandia lawsuits already … [Read more...] about Glaxo Settled 700 Avandia Lawsuits
Group Says Avandia Ups Risk For Liver Damage
Avandia Ups Risk For Liver Damage. According to emerging research, GlaxoSmithKline’s diabetes drug, Avandia, can cause death as a result of liver failure, and should be banned by the U.S. Food & Drug Administration (FDA). The group, Public Citizen, published the research in the peer-reviewed medical journal … [Read more...] about Group Says Avandia Ups Risk For Liver Damage
Another Byetta Delay
Byetta Probe Extension Sought. Federal regulators are extending a review of the diabetes drug Byetta into next year, Forbes.com is reporting. The Food & Drug Administration (FDA) is considering whether or not to approve Byetta as a stand-alone treatment for diabetes. Right now the drug, jointly marketed by Amylin … [Read more...] about Another Byetta Delay
Avandia Linked Increased Death Risk
Avandia Increase Risk Of Cardiovascular Events. According to a study published in a recent issue of the Archives of Internal Medicine, the diabetes drug rosiglitazone maleate—also known as Avandia—may increase the risk of certain cardiovascular events. The study, which was conducted by Dr. Wolfgang Winkelmayer of Brigham and … [Read more...] about Avandia Linked Increased Death Risk
Avandia Disappoints Again
Avandia Does Not Reduce Arterial Plaque. Avandia, GlaxoSmithKline's controversial diabetes drug, does not reduce arterial plaque buildup in any significant way, according to a new study. This news only adds to the uncertainty surrounding Avandia, which has been the subject of safety worries since it was tied to an increased risk of … [Read more...] about Avandia Disappoints Again
FDA Diabetes Drug Safety Alert
Diabetes Drug Avandia Linked To Heart Attacks. The widely prescribed diabetes drug Avandia is linked to a greater risk of heart attack and possibly death, a new scientific analysis revealed, and the U.S. government issued a safety alert Monday. The Food and Drug Administration urged diabetics taking the pill to talk to their … [Read more...] about FDA Diabetes Drug Safety Alert
Muraglitazar Potential Blockbuster Diabetes Drug
Muraglitazar Potentially Deadly Results. Noted experts fear Vioxx-like scenario is about to be repeated with potentially deadly results for those who would take the drug that is about to be approved for sale. An eagerly awaited diabetes drug, which is nearing final approval by the FDA, significantly increases the risk of … [Read more...] about Muraglitazar Potential Blockbuster Diabetes Drug
Novo Nordisk Shares May Fall After Warning on Diabetes Drug
Novo Nordisk Diabetes Drug Side Effect. Shares of Novo Nordisk A/S, the world's largest maker of diabetes drugs, may fall after the Danish company and Canadian regulators warned that Novo's GlucoNorm treatment may have a potentially fatal side effect when taken with another medicine. The combination of Novo's GlucoNorm … [Read more...] about Novo Nordisk Shares May Fall After Warning on Diabetes Drug
Pfizer Settles Diabetes Drug Lawsuit
Pfizer Diabetes Drug Lawsuit. A woman who said her liver was destroyed by Pfizer Inc.'s recalled diabetes drug, Rezulin, still faces the prospect of a transplant. But her attorneys say a settlement reached with the drug giant hours after it lost a huge jury verdict will bring her justice. The amount of the settlement was not … [Read more...] about Pfizer Settles Diabetes Drug Lawsuit
Rezulin Suit Settled Before Trial
Rezulin Lawsuit Settlement. Attorneys settled a $175 million lawsuit against the maker of Rezulin on Monday, averting the nation's first trial blaming a death on the diabetes drug. Details of the settlement, reached Monday in Hinds County Circuit Court in Raymond, were sealed. As part of the settlement, the drug's manufacturer, … [Read more...] about Rezulin Suit Settled Before Trial
